Cumulatively, the data shown in Fig 7 argue that VRK1 is frequently overexpressed in later stages of breast cancer (A-C) and that overexpression shows a statistically significant correlation with poor clinical outcome (7D, E). This evidence concerns the gene VRK1 and breast carcinoma.